Adamant Biomedical Investments
Latest statistics and disclosures from Adamant Biomedical Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Celgene Corporation, BIIB, GILD, AMGN, Actavis, and represent 20.15% of Adamant Biomedical Investments's stock portfolio.
- Added to shares of these 10 stocks: Hospira (+$5.5M), ACAD (+$5.4M), WuXi PharmaTech, Medivation, LGND, ABBV, ELV, Catamaran, Akorn, Clovis Oncology.
- Started 13 new stock positions in Hospira, Ims Health Holdings, ABBV, THC, Quintiles Transnatio Hldgs I, PAREXEL International Corporation, WuXi PharmaTech, Health Net, Asterias Biotherapeutics, ELV. LGND, Clovis Oncology, Biotime Inc wts oct 1 18.
- Reduced shares in these 10 stocks: Covidien (-$5.1M), , BIB, TEVA, Salix Pharmaceuticals, Qiagen, , CNC, RVNC, ISIS Pharmaceuticals.
- Sold out of its positions in Dendreon Corporation, TNA, PODD, Ldr Hldg, Organovo Holdings, RVNC, WellPoint, Wright Medical.
- Adamant Biomedical Investments was a net seller of stock by $-21M.
- Adamant Biomedical Investments has $418M in assets under management (AUM), dropping by 4.42%.
- Central Index Key (CIK): 0001542336
Portfolio Holdings for Adamant Biomedical Investments
Adamant Biomedical Investments holds 101 positions in its portfolio as reported in the December 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Celgene Corporation | 5.0 | $21M | -9% | 186k | 111.86 |
|
Biogen Idec (BIIB) | 4.3 | $18M | -3% | 53k | 339.46 |
|
Gilead Sciences (GILD) | 4.1 | $17M | -8% | 180k | 94.26 |
|
Amgen (AMGN) | 3.6 | $15M | -5% | 95k | 159.29 |
|
Actavis | 3.2 | $13M | 52k | 257.41 |
|
|
UnitedHealth (UNH) | 2.8 | $12M | -10% | 115k | 101.09 |
|
Mylan | 2.7 | $11M | -13% | 200k | 56.37 |
|
Catamaran | 2.6 | $11M | +51% | 207k | 51.91 |
|
Alexion Pharmaceuticals | 2.5 | $11M | -5% | 57k | 185.04 |
|
Medtronic | 2.1 | $8.8M | -19% | 122k | 72.20 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $8.7M | 73k | 118.79 |
|
|
Regeneron Pharmaceuticals (REGN) | 2.1 | $8.6M | +16% | 21k | 410.24 |
|
McKesson Corporation (MCK) | 2.0 | $8.5M | 41k | 207.59 |
|
|
Auris Med Hldg | 2.0 | $8.5M | 2.2M | 3.90 |
|
|
Mallinckrodt Pub | 1.9 | $7.9M | 80k | 99.02 |
|
|
Abbott Laboratories (ABT) | 1.9 | $7.8M | -13% | 173k | 45.02 |
|
Allergan | 1.8 | $7.4M | 35k | 212.60 |
|
|
Illumina (ILMN) | 1.8 | $7.4M | -6% | 40k | 184.58 |
|
ACADIA Pharmaceuticals (ACAD) | 1.6 | $6.5M | +485% | 205k | 31.75 |
|
Medivation | 1.6 | $6.5M | +225% | 65k | 99.62 |
|
Cardinal Health (CAH) | 1.5 | $6.5M | -23% | 80k | 80.72 |
|
ISIS Pharmaceuticals | 1.5 | $6.2M | -28% | 100k | 61.74 |
|
Akorn | 1.4 | $5.8M | +166% | 160k | 36.20 |
|
Eli Lilly & Co. (LLY) | 1.3 | $5.5M | 80k | 68.99 |
|
|
Hospira | 1.3 | $5.5M | NEW | 90k | 61.24 |
|
Centene Corporation (CNC) | 1.3 | $5.4M | -34% | 52k | 103.86 |
|
Salix Pharmaceuticals | 1.2 | $5.2M | -42% | 45k | 114.93 |
|
CIGNA Corporation | 1.2 | $5.1M | 50k | 102.92 |
|
|
Incyte Corporation (INCY) | 1.2 | $5.1M | 70k | 73.11 |
|
|
Molina Healthcare (MOH) | 1.2 | $4.9M | -30% | 92k | 53.53 |
|
Express Scripts Holding | 1.1 | $4.8M | 57k | 84.67 |
|
|
Baxter International (BAX) | 1.1 | $4.8M | 65k | 73.29 |
|
|
Brookdale Senior Living (BKD) | 1.1 | $4.8M | -5% | 130k | 36.67 |
|
WuXi PharmaTech | 1.1 | $4.7M | NEW | 140k | 33.67 |
|
Humana (HUM) | 1.0 | $4.3M | -14% | 30k | 143.63 |
|
Ligand Pharmaceuticals In (LGND) | 1.0 | $4.3M | NEW | 81k | 53.21 |
|
Johnson & Johnson (JNJ) | 1.0 | $4.2M | -11% | 40k | 104.58 |
|
Lannett Company | 1.0 | $4.0M | +17% | 94k | 42.88 |
|
Hca Holdings (HCA) | 1.0 | $4.0M | +22% | 55k | 73.38 |
|
Stryker Corporation (SYK) | 0.9 | $3.9M | -27% | 42k | 94.34 |
|
Abbvie (ABBV) | 0.9 | $3.9M | NEW | 60k | 65.43 |
|
Aetna | 0.9 | $3.9M | -26% | 44k | 88.84 |
|
Anthem (ELV) | 0.9 | $3.8M | NEW | 30k | 125.67 |
|
Bristol Myers Squibb (BMY) | 0.8 | $3.5M | +20% | 60k | 59.03 |
|
Perrigo Company (PRGO) | 0.8 | $3.3M | -34% | 20k | 166.65 |
|
St. Jude Medical | 0.8 | $3.3M | -21% | 51k | 65.04 |
|
BioMarin Pharmaceutical (BMRN) | 0.8 | $3.3M | -28% | 36k | 90.39 |
|
Jazz Pharmaceuticals (JAZZ) | 0.8 | $3.3M | 20k | 163.75 |
|
|
Teva Pharmaceutical Industries (TEVA) | 0.7 | $2.9M | -58% | 50k | 57.52 |
|
CVS Caremark Corporation (CVS) | 0.7 | $2.9M | -33% | 30k | 96.30 |
|
Endo International (ENDPQ) | 0.7 | $2.9M | 40k | 72.12 |
|
|
Zimmer Holdings (ZBH) | 0.7 | $2.8M | 25k | 113.44 |
|
|
Clovis Oncology | 0.7 | $2.8M | NEW | 50k | 56.00 |
|
Alkermes (ALKS) | 0.6 | $2.6M | 45k | 58.56 |
|
|
Cerner Corporation | 0.6 | $2.6M | 40k | 64.65 |
|
|
Dr. Reddy's Laboratories (RDY) | 0.6 | $2.5M | -37% | 50k | 50.44 |
|
Cubist Pharmaceuticals | 0.6 | $2.4M | 24k | 100.67 |
|
|
Shire | 0.6 | $2.3M | 11k | 212.55 |
|
|
Qiagen | 0.6 | $2.3M | -60% | 100k | 23.43 |
|
Merck & Co (MRK) | 0.5 | $2.3M | 40k | 56.80 |
|
|
PAREXEL International Corporation | 0.5 | $2.2M | NEW | 40k | 55.55 |
|
Alnylam Pharmaceuticals (ALNY) | 0.5 | $2.2M | 23k | 97.00 |
|
|
Intuitive Surgical (ISRG) | 0.5 | $2.1M | 4.0k | 529.00 |
|
|
Ariad Pharmaceuticals | 0.5 | $2.1M | 300k | 6.87 |
|
|
DaVita (DVA) | 0.5 | $2.0M | 26k | 75.73 |
|
|
Pfizer (PFE) | 0.5 | $1.9M | 60k | 31.15 |
|
|
Proshares Tr pshs ult nasb (BIB) | 0.5 | $1.9M | -70% | 15k | 125.47 |
|
Edwards Lifesciences (EW) | 0.4 | $1.8M | 15k | 127.38 |
|
|
Tenet Healthcare Corporation (THC) | 0.4 | $1.8M | NEW | 35k | 50.66 |
|
Varian Medical Systems | 0.4 | $1.7M | 20k | 86.50 |
|
|
C.R. Bard | 0.4 | $1.7M | 10k | 166.60 |
|
|
Omnicare | 0.4 | $1.7M | +27% | 23k | 72.91 |
|
Health Net | 0.4 | $1.6M | NEW | 30k | 53.53 |
|
MannKind Corporation | 0.4 | $1.6M | 300k | 5.21 |
|
|
athenahealth | 0.3 | $1.5M | 10k | 145.70 |
|
|
Medicines Company | 0.3 | $1.4M | 50k | 27.68 |
|
|
Seattle Genetics | 0.3 | $1.3M | 40k | 32.12 |
|
|
NPS Pharmaceuticals | 0.3 | $1.2M | 34k | 35.76 |
|
|
Achillion Pharmaceuticals | 0.3 | $1.2M | +25% | 100k | 12.25 |
|
ResMed (RMD) | 0.3 | $1.1M | -66% | 20k | 56.05 |
|
Neurocrine Biosciences (NBIX) | 0.2 | $1.0M | 45k | 22.33 |
|
|
Covidien | 0.2 | $1.0M | -83% | 10k | 102.30 |
|
AmerisourceBergen (COR) | 0.2 | $902k | 10k | 90.20 |
|
|
United Therapeutics Corporation (UTHR) | 0.2 | $906k | -53% | 7.0k | 129.43 |
|
Myriad Genetics (MYGN) | 0.2 | $817k | 24k | 34.04 |
|
|
Immunomedics | 0.2 | $720k | 150k | 4.80 |
|
|
WellCare Health Plans | 0.2 | $656k | 8.0k | 82.00 |
|
|
Impax Laboratories | 0.1 | $634k | 20k | 31.70 |
|
|
Halozyme Therapeutics (HALO) | 0.1 | $579k | 60k | 9.65 |
|
|
Quintiles Transnatio Hldgs I | 0.1 | $589k | NEW | 10k | 58.90 |
|
Celldex Therapeutics | 0.1 | $548k | 30k | 18.27 |
|
|
Affymetrix | 0.1 | $494k | -50% | 50k | 9.88 |
|
Theravance | 0.1 | $495k | -65% | 35k | 14.14 |
|
Exelixis (EXEL) | 0.1 | $432k | 300k | 1.44 |
|
|
Infinity Pharmaceuticals (INFIQ) | 0.1 | $287k | 17k | 16.88 |
|
|
Ims Health Holdings | 0.1 | $256k | NEW | 10k | 25.60 |
|
Theravance Biopharma (TBPH) | 0.0 | $171k | 11k | 14.96 |
|
|
Geron Corporation (GERN) | 0.0 | $146k | 45k | 3.24 |
|
|
Cubist Pharmaceutic-cvr | 0.0 | $3.2k | 80k | 0.04 |
|
|
Asterias Biotherapeutics | 0.0 | $6.0k | NEW | 1.9k | 3.20 |
|
Biotime Inc wts oct 1 18 | 0.0 | $2.0k | NEW | 2.3k | 0.87 |
|
Past Filings by Adamant Biomedical Investments
SEC 13F filings are viewable for Adamant Biomedical Investments going back to 2014
- Adamant Biomedical Investments 2014 Q4 filed Feb. 13, 2015
- Adamant Biomedical Investments 2014 Q3 filed Nov. 14, 2014